JP2021503960A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021503960A5 JP2021503960A5 JP2020546302A JP2020546302A JP2021503960A5 JP 2021503960 A5 JP2021503960 A5 JP 2021503960A5 JP 2020546302 A JP2020546302 A JP 2020546302A JP 2020546302 A JP2020546302 A JP 2020546302A JP 2021503960 A5 JP2021503960 A5 JP 2021503960A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- pharmaceutical composition
- vector
- engineered
- engineered receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024105712A JP2024160218A (ja) | 2017-11-27 | 2024-06-28 | 神経疾患のための組成物および方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762590911P | 2017-11-27 | 2017-11-27 | |
| US62/590,911 | 2017-11-27 | ||
| US201862659911P | 2018-04-19 | 2018-04-19 | |
| US62/659,911 | 2018-04-19 | ||
| PCT/US2018/062575 WO2019104307A1 (en) | 2017-11-27 | 2018-11-27 | Compositions and methods for neurological diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024105712A Division JP2024160218A (ja) | 2017-11-27 | 2024-06-28 | 神経疾患のための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021503960A JP2021503960A (ja) | 2021-02-15 |
| JP2021503960A5 true JP2021503960A5 (cg-RX-API-DMAC7.html) | 2022-01-04 |
Family
ID=66632192
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546302A Pending JP2021503960A (ja) | 2017-11-27 | 2018-11-27 | 神経疾患のための組成物および方法 |
| JP2024105712A Pending JP2024160218A (ja) | 2017-11-27 | 2024-06-28 | 神経疾患のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024105712A Pending JP2024160218A (ja) | 2017-11-27 | 2024-06-28 | 神経疾患のための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10538571B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3716990A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021503960A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20200112811A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111741760A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2018373279B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3082907A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL274702B2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2020005470A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202004488TA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019104307A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202408862B (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020222881C1 (en) | 2019-02-13 | 2026-01-22 | Ptc Therapeutics, Inc. | Thioeno(3,2-b) pyridin-7-amine compounds for treating familial dysautonomia |
| WO2020167624A1 (en) | 2019-02-13 | 2020-08-20 | Ptc Therapeutics, Inc. | Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia |
| JP7781052B2 (ja) * | 2019-08-21 | 2025-12-05 | トレイムス バイオ, インコーポレイテッド | 神経学的疾患のための組成物および方法 |
| US20230102192A1 (en) * | 2020-02-20 | 2023-03-30 | The Regents Of The University Of California | Therapies for the treatment of diseases and disorders associated with abnormal expression of a neural-associated gene |
| AU2021329529A1 (en) * | 2020-08-21 | 2023-04-27 | Trames Bio, Inc. | Compositions and methods for neurological diseases |
| WO2022067044A1 (en) * | 2020-09-25 | 2022-03-31 | The Regents Of The University Of California | Compositions and methods for ameliorating medical conditions |
| JP2024505197A (ja) * | 2021-01-25 | 2024-02-05 | トレイムス バイオ, インコーポレイテッド | 焦点てんかんおよび神経因性疼痛を処置するためのアデノ随伴ウイルスカプシドおよび操作されたリガンド依存性イオンチャネル |
| US11969400B2 (en) * | 2021-03-23 | 2024-04-30 | Kumara V. Nibhanipudi | Ibuprofen for symptomatic treatment of diarrheas in HIV patients |
| WO2023278295A1 (en) | 2021-06-29 | 2023-01-05 | The Broad Institute, Inc. | Compositions and methods for ameliorating anterodorsal thalamus hyperexcitability |
| CN113730809B (zh) * | 2021-10-09 | 2024-08-16 | 科悦医疗(苏州)有限公司 | 一种非侵入式迷走神经联合骶神经刺激装置 |
| US20250145687A1 (en) * | 2022-01-31 | 2025-05-08 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
| CN119343455A (zh) * | 2022-01-31 | 2025-01-21 | 特拉梅斯生物股份有限公司 | 用于治疗癫痫和神经性疼痛的表达盒 |
| IL315059A (en) * | 2022-02-18 | 2024-10-01 | Trames Bio Inc | Ion channels that open using ligands and methods of using them |
| AU2023222147A1 (en) * | 2022-02-18 | 2024-09-12 | Trames Bio, Inc. | Compositions and methods for neurological diseases |
| WO2025015092A1 (en) * | 2023-07-10 | 2025-01-16 | Kriya Therapeutics, Inc. | Novel cam-kinase promoter and uses thereof for treating nervous system disorders |
| CN121866054A (zh) * | 2023-08-16 | 2026-04-14 | 拜尔吉生物股份有限公司 | 用于治疗癫痫发作的方法 |
| GB202401492D0 (en) | 2024-02-05 | 2024-03-20 | Ucl Business Ltd | Chloride channels and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3628691B2 (ja) * | 1993-03-08 | 2005-03-16 | メルク エンド カンパニー インコーポレーテッド | ヒト神経細胞性ニコチン性アセチルコリン受容体組成物およびそれらの使用方法 |
| EP0733103B1 (en) | 1993-11-09 | 2004-03-03 | Targeted Genetics Corporation | Generation of high titers of recombinant aav vectors |
| WO1997035478A1 (en) | 1996-03-26 | 1997-10-02 | The Regents Of The University Of California | Selective target cell activation by expression of a g protein-coupled receptor activated superiorly by synthetic ligand |
| FR2756297B1 (fr) | 1996-11-22 | 1999-01-08 | Centre Nat Rech Scient | Procede de production de virus recombinants |
| WO1999006562A1 (en) | 1997-07-31 | 1999-02-11 | Chiron Corporation | Method enabling readministration of aav vector via immunosuppression of host |
| CA2995542A1 (en) | 1997-09-05 | 1999-03-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of recombinant aav vectors |
| US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| EP1135468B1 (en) | 1998-11-10 | 2010-01-06 | University Of North Carolina At Chapel Hill | Virus vectors and methods of making and administering the same |
| WO2000073431A2 (en) | 1999-05-27 | 2000-12-07 | Pharmacia & Upjohn Company | Methods and compositions for measuring ion channel conductance |
| US6498244B1 (en) | 1999-05-28 | 2002-12-24 | Cell Genesys, Inc. | Adeno-associated virus capsid immunologic determinants |
| WO2001023001A2 (en) | 1999-09-29 | 2001-04-05 | The Trustees Of The University Of Pennsylvania | Rapid peg-modification |
| AU2001257378A1 (en) | 2000-04-29 | 2001-11-12 | Millennium Pharmaceuticals, Inc. | 23949 and 32391, human ion channels and uses thereof |
| US7883846B2 (en) | 2002-05-31 | 2011-02-08 | Sloan-Kettering Institute For Cancer Research | Heterologous stimulus-gated ion channels and methods of using same |
| PL2657248T3 (pl) | 2003-06-19 | 2017-09-29 | Genzyme Corporation | Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US20060166363A1 (en) | 2004-01-27 | 2006-07-27 | Sergei Zolotukhin | Modified baculovirus expression system for production of pseudotyped rAAV vector |
| WO2008143875A1 (en) | 2007-05-14 | 2008-11-27 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Targeted delivery of glycine receptors to excitable cells |
| WO2010042799A2 (en) | 2008-10-09 | 2010-04-15 | Howard Hughes Medical Institute | Novel chimeric ligand-gated ion channels and methods of use thereof |
| US9624288B2 (en) * | 2012-12-10 | 2017-04-18 | University of Pittsburgh—of the Commonwealth System of Higher Education | Engineered receptors and their use |
| GB201404470D0 (en) | 2014-03-13 | 2014-04-30 | Ucl Business Plc | Therapeutic methods and materials |
| US10682424B2 (en) | 2015-03-31 | 2020-06-16 | New York University | Compositions and method for reducing seizures |
| AU2016324317A1 (en) | 2015-09-17 | 2018-03-08 | Coda Biotherapeutics, Inc. | Compositions and methods for treating neurological disorders |
| IL311984A (en) | 2016-07-07 | 2024-06-01 | Hughes Howard Med Inst | Modified ligand-gated ion channels and methods of use |
| US11713470B2 (en) | 2017-03-20 | 2023-08-01 | University of Pittsburgh—of the Commonwealth System of Higher Education | Targeted gene therapies for pain and other neuro-related disorders |
-
2018
- 2018-11-27 IL IL274702A patent/IL274702B2/en unknown
- 2018-11-27 CN CN201880085562.7A patent/CN111741760A/zh active Pending
- 2018-11-27 CA CA3082907A patent/CA3082907A1/en active Pending
- 2018-11-27 US US16/201,142 patent/US10538571B2/en active Active
- 2018-11-27 SG SG11202004488TA patent/SG11202004488TA/en unknown
- 2018-11-27 MX MX2020005470A patent/MX2020005470A/es unknown
- 2018-11-27 AU AU2018373279A patent/AU2018373279B2/en active Active
- 2018-11-27 KR KR1020207016109A patent/KR20200112811A/ko not_active Ceased
- 2018-11-27 EP EP18881318.2A patent/EP3716990A4/en active Pending
- 2018-11-27 WO PCT/US2018/062575 patent/WO2019104307A1/en not_active Ceased
- 2018-11-27 KR KR1020267002196A patent/KR20260030128A/ko active Pending
- 2018-11-27 JP JP2020546302A patent/JP2021503960A/ja active Pending
-
2020
- 2020-07-09 US US16/925,174 patent/US20210061873A1/en active Pending
- 2020-07-13 MX MX2024014448A patent/MX2024014448A/es unknown
-
2024
- 2024-06-28 JP JP2024105712A patent/JP2024160218A/ja active Pending
- 2024-10-23 AU AU2024227560A patent/AU2024227560B2/en active Active
- 2024-11-21 ZA ZA2024/08862A patent/ZA202408862B/en unknown
-
2025
- 2025-11-19 IL IL324810A patent/IL324810A/en unknown